Kevin Rodriguez+FollowModerna’s RSV Shot Just Got a Big BoostModerna’s RSV vaccine just scored FDA approval for younger adults (18-59) with health issues—previously, it was only for those 60+. The move comes as RSV risks for under-60s are often overlooked, but a ton of people in that group have conditions that put them at risk. Meanwhile, vaccine policy is getting a shake-up with RFK Jr. bringing in new advisors (some anti-vax!), and Moderna’s stock is feeling the heat. Big pharma drama and health news all in one! #Moderna #RSV #FDA #Health #BodyHealth90Share
nheath+FollowModerna’s New Covid Shot: What’s the Deal?Moderna just scored FDA approval for a new Covid vaccine, but there’s a catch—it’s only for folks 65+ or those 12-64 with health risks. The new shot, mNexspike, uses just a fifth of the dose of their old vaccine but still packs a punch. It’s not replacing the OG shot, just giving high-risk people another option. Basically, it’s a big move for next-gen vaccines, but don’t expect to see it everywhere just yet! #CovidVaccine #Moderna #FDA #Health1518Share
Melanie James+FollowCucumber Recall Drama: 15 States Hit!Did you hear about the cucumber chaos? The FDA just recalled cucumbers across 15 states after a salmonella outbreak—26 people got sick, and 9 ended up in the hospital! The veggies came from Bedner Growers in Florida and were sold everywhere, even on cruise ships. The worst part? They might not even have labels, so it’s hard to know if you’ve got the bad batch. If you bought cucumbers recently, double-check before you eat! #FoodRecall #Salmonella #FDA #Health41Share
nheath+FollowFDA’s New COVID Vax Plan Has Docs SplitBig shakeup in the COVID vaccine world! The FDA’s advisors just voted to update shots for the JN.1 strain, but the real drama? The FDA’s hinting at a new plan: only high-risk folks and seniors might get recommended for future boosters, not everyone. Experts are totally split on which strain to target next, and there’s a lot of side-eye about how this will affect vaccine makers like Novavax and Sanofi. Meanwhile, political pushback is heating up. Stay tuned—this could change how we all get vaxxed! #COVID19 #FDA #Vaccines #Health01Share
Barry Miller+FollowFDA’s COVID Vax Shake-Up: Only for High-Risk?Big news: The FDA just changed the COVID vaccine game! Now, only folks 65+ or those at high risk are getting the official vax recommendation. No more annual shots for everyone—healthy kids and adults under 65 are off the list unless new trials prove it’s worth it. The move follows super low booster rates and puts the US in line with other countries. Some are worried this could fuel more vaccine hesitancy. What do you think about this switch? #COVID19 #FDA #VaccineUpdate #HealthNews #PublicHealth #Health30Share
Spencer Brewer+FollowCOVID Vax Rules Are Getting a Shake-UpBig changes are coming for COVID-19 vaccines! The FDA wants annual boosters for healthy people under 65 to go through clinical trials first, which means most folks might not get a shot this fall unless they’re older or at higher risk. Plus, Pfizer and Moderna are being told to add warning labels about rare heart inflammation in young men. The science is still evolving, so stay tuned if you’re wondering about your next dose! #COVID19 #VaccineUpdate #FDA #HealthNews #Health141Share
Barry Miller+FollowWho Can Still Get COVID Shots?Big change alert: The FDA just announced that starting in 2025, only people 65+ or those with certain health conditions will have easy access to COVID vaccines. If you’re younger and healthy, getting your annual shot is about to get way harder. With anti-vax voices gaining power, the days of free-for-all COVID boosters are over. Docs are worried this could mean more unnecessary deaths. What do you think about the new rules? #COVID19 #FDA #Vaccines #HealthNews #PublicHealth #Health12Share
Melanie James+FollowFDA Narrows COVID Vax—Who’s Still Eligible?Big shift: The FDA just announced that only adults 65+ and people with certain health risks (think asthma, cancer, diabetes, etc.) will be able to get the new COVID-19 vaccine this fall. Healthy younger adults and kids? Not on the list unless new trials prove it’s worth it. This move is sparking debate—some say it’s about safety, others worry it’ll make vaccines harder to get and fuel more hesitancy. What do you think about this new approach? #COVID19 #VaccineUpdate #FDA #PublicHealth #VaccineNews #Health20Share
Spencer Brewer+FollowModerna’s Combo Vax Hits a RoadblockModerna just yanked its FDA application for their much-hyped combo flu/COVID shot, even after saying it worked better than current vaccines. Turns out, the FDA wants more data, so Moderna’s pushing approval back to 2026 and deprioritizing the shot for now. Their stock dropped 4.5% on the news. They’ll try again later this year when more trial results come in. Meanwhile, the FDA’s getting stricter on vaccine approvals, and Pfizer’s racing ahead with its own combo vax. Wild times in vaccine land! #Moderna #VaccineNews #Biotech #FDA #COVID19 #Health10Share
nheath+FollowFDA’s COVID Vax Move Sparks OutrageThe FDA just dropped a bomb: COVID vaccines might only be available for people over 65 or those at high risk. That means healthy adults under 65 could be out of luck until more studies are done. CT health experts are calling this 'borderline unethical'—especially since the vax has been studied like crazy. People are worried about losing their shot at protection, and honestly, the irony isn’t lost on anyone. What do you think: smart move or total misstep? #COVID19 #VaccineNews #FDA #HealthDebate #Connecticut #Health5682Share
